Home Compare COLO-B.CO vs IPN.PA
Stock Comparison · Valuation-led comparison

Coloplast A/S vs Ipsen: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Coloplast A/S carrying a narrow edge on valuation. The remaining gap is narrow enough that the comparison remains open to different readings. In the market, Ipsen carries the stronger setup — intact trend against Coloplast A/S's broken trend. That leaves a split case: the structural lead stays with Coloplast A/S, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Most of the separation is still concentrated in valuation.

Trajectory Similarity
0.72
Similar
Peer-set rank: #3
within Coloplast A/S's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The strongest overlap appears in capital structure and revenue stability.

Similarity drivers
capital structurerevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
COLO-B.CO
Coloplast A/S
53
Peer-Score
Signal qualityHigh
vs
IPN.PA
Ipsen S.A.
50
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing shapes this comparison more than a broad operating gap.

Dimension spread: COLO-B.CO vs IPN.PA Profitability 57 51 Stability 56 57 Valuation 54 43 Growth 44 51 COLO-B.CO IPN.PA
Gap Ranking
#1 Valuation +11
#2 Growth +7
#3 Profitability +6
#4 Stability +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COLO-B.CO and IPN.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer COLO-B.COIPN.PA Relative valuation Structural strength

The structural gap is limited here, but current pricing still leans against Ipsen S.A..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Both rank well on valuation, but Coloplast A/S still sits higher.
Valuation — Dominant Gap
COLO-B.CO
54
IPN.PA
43
Gap+11in favour of COLO-B.CO

The multiple-based pricing edge comes from a trailing P/E that is 6.4 turns lower.

What keeps the gap from being one-sided

On the market side, Ipsen carries the stronger trend while Coloplast A/S's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is visible, but pricing still does more of the work than the broader operating profile.

Explore full peer positioning in AssetNext

Break down the COLO-B.CO vs IPN.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other close comparisons

Explore how COLO-B.CO and IPN.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.